Among the principal regulatory cascades for skeletal development are Hox genes that determine the timing, position and shape of a tissue element during embryogenesis. Hox and other homeodomain (HD) transcription factors also function in the adult skeleton to support osteoblast differentiation [Depew et al., 2005; Zakany and Duboule, 2007] . The BMP2 osteogenic signal activates several Hox and HD proteins as early response genes. HOXA10 and DLX3 and DLX5 HD proteins were characterized as enhancers of osteoblast gene transcription on gene promoters [Hassan et al., , 2007 . RUNX2, the transcription factor essential for bone formation, interacts with genes on mitotic chromosomes as an epigenetic mechanism for development of the osteoblast phe-
Introduction
Among the principal regulatory cascades for skeletal development are Hox genes that determine the timing, position and shape of a tissue element during embryogenesis. Hox and other homeodomain (HD) transcription factors also function in the adult skeleton to support osteoblast differentiation [Depew et al., 2005; Zakany and Duboule, 2007] . The BMP2 osteogenic signal activates several Hox and HD proteins as early response genes. HOXA10 and DLX3 and DLX5 HD proteins were characterized as enhancers of osteoblast gene transcription on gene promoters [Hassan et al., , 2007 . RUNX2, the transcription factor essential for bone formation, interacts with genes on mitotic chromosomes as an epigenetic mechanism for development of the osteoblast phe- notype [Young et al., 2007b] , attenuates global protein synthesis [Young et al., 2007a] and integrates osteogenic signals through phosphorylation of Runx2 and formation of complexes with the coregulatory proteins that transduce the response to gene targets . Here, we have used two signature osteoblast-specific gene promoters (Runx2 and OC) as models to probe interactions of HOXA10, MSX2, DLX3, DLX5 and RUNX2 with chromatin of target genes for their induced and physiological expression during stages of osteoblastogenesis.
Materials and Methods

Western Blotting
Electrophoresis conditions and Western blotting have been described previously .
Chromatin Immunoprecipitation Assays
The procedures for chromatin immunoprecipitation in primary rat osteoblasts are detailed elsewhere [Hassan et al., , 2007 . The cross-linked rat calvarial osteoblast cells were lysed and sonicated using appropriate conditions. Precleared soluble chromatins were immunoprecipitated with specific antibodies. DNA fragments were purified from the immunocomplexes and specific promoters analyzed by PCR.
Small Interfering RNA HOXA10 siRNA was obtained from Qiagen and protein knockdown tested against a nonspecific siRNA duplex oligo using antibodies to HOXA10 from Santa Cruz [Hassan et al., 2007] .
Results
Transcriptional mechanisms that program osteoblast growth and differentiation include DNA binding of regulatory complexes and chromatin modifications for activation and repression of a gene during stages of differentiation ( fig. 1 a) . Western blot analyses reveal changing protein levels of the transcription factors during osteoblast maturation ( fig. 1 b) . Although MSX2 decreases, RUNX2, DLX3 and DLX5 increase to maximal levels with formation of bone nodules (day 12 in primary rat calvarial cells). The chromatin immunoprecipitation studies define the in vivo occupancy of the factors on the respective gene promoters ( fig. 1 c, d ). We found a temporal recruitment of HD proteins in relation to Runx2 ( fig. 1 c) and OC ( fig. 1 d) transcription. MSX2 is associated with both promoters only in the proliferation period (day 4) and is no longer bound to both of them by day 12 despite significant cellular MSX2 levels ( fig. 1 b) . On day 12 both DLX3 and DLX5, together with RUNX2, are recruited to the Runx2 and OC promoters. A concomitant increase in RNA polymerase II occurs at this time reflecting induced transcription. However, DLX3 binding to Runx2 is transient in the matrix maturation stage of differentiation with preferential binding of DLX5 at later stages. This suggests an important role for DLX5 in the HD network to regulate terminal differentiation. In the mineralization stage, an increased association of RUNX2 to OC is accompanied by maximal expression of the gene. However, the increased binding of RUNX2 to its own promoter results in a slight decrease in cellular protein; yet, transcription is maintained as indicated by RNA polymerase II binding and likely sustained by DLX5 binding. Thus Runx2 and OC are examples of a coordinated temporal regulation by an HD network, and with RUNX2, these factors support the timing of expression and physiological levels of target genes during osteoblast differentiation.
The early association of HOXA10, prior to RUNX2, on bone-related gene promoters when expression is very low (Runx2) or not detected (BSP, OC), indicates a specialized function ( fig. 1 c, d ). We previously reported the effects of HOXA10 depletion (by siRNA) on histone acetylation and H3K4 methylation of gene promoters, which reflect transcriptionally active chromatin [Hassan et al., 2007] . Our findings showed a significant decrease in acetylation of Runx2, BSP and OC chromatin in the absence of HOXA10 in osteoblasts. From these studies, a pattern emerges that defines functional activities of HOXA10, HD proteins and RUNX2 and a mechanism for activating gene transcription and regulating their temporal expression profile during stages of osteoblast maturation.
Discussion
There is a requirement for chromatin remodeling of genes silenced by condensed chromatin for BMP2 induction of osteogenesis [Young et al., 2005] . The signals for induction of tissue-specific genes occur at multiple levels of control as indicated by the presented studies ( fig. 2 ) . RUNX2 functions in bone-specific activation by supporting chromatin modification. This was established by mutation of the Runx2 sites in the OC gene [Javed et al., 1999] . We propose that the recruitment of HOXA10 to gene promoters prior to RUNX2 binding may fulfill several roles. HOXA10 complexes with the corepressors PBX and MEIS as well as coactivators such as p300 [Saleh et al., 2000; Capellini et al., 2006] . Its binding to bone promoters prior to Runx2 suggests an epigenetic modification without transcription that later contributes to activation. Another level of gene regulation is needed for physiological control of transcription driven by cellular representation of the factors and formation of heterodimeric complexes with coregulatory factors ( fig. 2 ) that may alter DNA-binding affinity. We postulate that the MSX and DLX HD proteins function to regulate the timing of stage-specific gene expression coordinated with requirement for RUNX2 and HOXA10. In summary, combinatorial mechanisms are operative for regulated transcription of osteoblast genes through diversification of both sequence-specific activators/repressors that contribute to patterns of gene expression and the multistep process of programming involved in bone formation. 
